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Macrocystic pancreatic tumors seem to play an important role among neoplas-
tic lesions of the pancreas as they sometimes either show a malignant potential or 
they already have neoplastic foci inside the cystic tumor. Differential diagnosis is a 
key factor in comparison with other cystic tumors which are not malignant as Serous 
Cystic Tumors (SCTs) and Mucinous Cystic Tumors (MCTs). So diagnostic imaging 
has become more and more important.
Since May 2009 we have observed more than 200 patients with cystic lesions of 
the pancreas. All the patients underwent a CholangioPancreato MagneticResonance 
(CPMR) after an Ultrasound and/or a CT scan. Then we excluded from our study 
solid lesions, pseudocysts and tumors with clear signs of malignancy. CPMR was 
sometimes performed also using a secretine test. Finally 51 patients were evaluated 
and underwent a follow up programme till now.
Among these patients we found 34 Intraductal Papillary Mucinous Neoplasia 
(IPMN), 7 MCTs and 10 SCTs. As we know that all SCTs show a lobulated septate pat-
tern, differential diagnosis with IPMN is mandatory in order to give to the patient the 
treatment of choice. CPMR revealed in 32 out of 34 IPMN patients a communication 
between the lesion and the main pancreatic duct (MPD); so this sign, which is patog-
nomonic of IPMN neoplasia, confirmed the diagnosis. All lesions > than 3 cm were 
resected by surgery (4 MCTs and 3 IPMN). Definitive histology always confirmed pre-
operative diagnostic imaging. Now the patients are all disease free at follow up. The 
other 44 patients undergo CPMR every 6 months following a “wait and see” policy.
CPMR seems to be fundamental for the diagnostic screening of IPMN. This is a 
simple, safe and non invasive procedure which allows an early diagnosis and a better 
chance of cure for this kind of patients.
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